Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View

Sodium–glucose cotransporter 2 inhibitors (SGLT2i), or gliflozins, have recently been shown to reduce cardiovascular death and hospitalization in patients with heart failure, representing a revolutionary therapeutic tool. The purpose of this review is to explore their multifaceted mechanisms of acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperi, Silvia, D’Amato, Andrea, Severino, Paolo, Myftari, Vincenzo, Monosilio, Sara, Marchiori, Ludovica, Zagordi, Lucrezia Maria, Filomena, Domenico, Di Pietro, Gianluca, Birtolo, Lucia Ilaria, Badagliacca, Roberto, Mancone, Massimo, Maestrini, Viviana, Vizza, Carmine Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530908/
https://www.ncbi.nlm.nih.gov/pubmed/37762152
http://dx.doi.org/10.3390/ijms241813848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530908/
https://www.ncbi.nlm.nih.gov/pubmed/37762152
http://dx.doi.org/10.3390/ijms241813848

Ejemplares similares